- Home
- AMBC vs EYPT Comparison
AMBC vs EYPT Comparison
Compare AMBC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- EYPT
- Stock Information
- Founded
- AMBC 1971
- EYPT 1987
- Country
- AMBC United States
- EYPT United States
- Employees
- AMBC N/A
- EYPT N/A
- Industry
- AMBC Property-Casualty Insurers
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- AMBC Finance
- EYPT Industrials
- Exchange
- AMBC Nasdaq
- EYPT Nasdaq
- Market Cap
- AMBC 392.1M
- EYPT 967.4M
- IPO Year
- AMBC 1991
- EYPT 2005
- Fundamental
- Price
- AMBC $9.08
- EYPT $13.75
- Analyst Decision
- AMBC Strong Buy
- EYPT Strong Buy
- Analyst Count
- AMBC 1
- EYPT 5
- Target Price
- AMBC $15.00
- EYPT $29.60
- AVG Volume (30 Days)
- AMBC 788.1K
- EYPT 1.4M
- Earning Date
- AMBC 11-10-2025
- EYPT 11-05-2025
- Dividend Yield
- AMBC N/A
- EYPT N/A
- EPS Growth
- AMBC N/A
- EYPT N/A
- EPS
- AMBC N/A
- EYPT N/A
- Revenue
- AMBC $254,480,000.00
- EYPT $42,339,000.00
- Revenue This Year
- AMBC $3.54
- EYPT N/A
- Revenue Next Year
- AMBC N/A
- EYPT N/A
- P/E Ratio
- AMBC N/A
- EYPT N/A
- Revenue Growth
- AMBC 142.82
- EYPT N/A
- 52 Week Low
- AMBC $5.99
- EYPT $3.91
- 52 Week High
- AMBC $13.64
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- AMBC 53.11
- EYPT 59.61
- Support Level
- AMBC $8.13
- EYPT $11.30
- Resistance Level
- AMBC $9.69
- EYPT $14.67
- Average True Range (ATR)
- AMBC 0.49
- EYPT 1.05
- MACD
- AMBC 0.05
- EYPT 0.28
- Stochastic Oscillator
- AMBC 42.92
- EYPT 79.48
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.